1

Pharmacy and Therapeutics (P&T) Committee

The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).

The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.

2023 Meeting Schedule and Handouts

Our meeting is held virtually. The meeting link will be posted just prior to the meeting for public attendees.

1:00 p.m. - 5:00 p.m.

The Committee meets once quarterly in January, April, July, and October.

October 3, 2023

OUR MEETING IS HELD VIRTUALLY

Zoom Webinar Registration Link:
https://magellanhealth.zoom.us/webinar/register/WN_-nlitHUeSp6SLKMr6I23ww

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

July 11, 2023

OUR MEETING IS HELD VIRTUALLY

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

April 4, 2023

OUR MEETING IS HELD VIRTUALLY

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

January 10, 2023

OUR MEETING IS HELD VIRTUALLY

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

2022 Meeting Schedule and Handouts

Our meeting is held virtually. The meeting link will be posted just prior to the meeting for public attendees.

1:00 p.m. - 5:00 p.m.

The Committee meets once quarterly in January, April, July, and October.

October 4, 2022

OUR MEETING IS HELD VIRTUALLY

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

July 12, 2022

OUR MEETING IS HELD VIRTUALLY

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

April 12, 2022

OUR MEETING IS HELD VIRTUALLY

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

January 11, 2022

OUR MEETING IS HELD VIRTUALLY

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

Our Members

The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.

January 2022 - December 2023 Term

Gwen Black, PharmD, BCACP

Thuy McKitrick, PharmD, BCACP

Paulette Campbell, PharmD

Kelet Robinson, MD

Marisa Wiktor, DO

January 2023 - December 2024 Term

Emily Kosirog, PharmD, BCACP

Daralyn Morgenson, PharmD, BCPP

Morgan Alonzo, PharmD

Jamie Feinstein, MD, MPH

George Athey, MD, PhD, FAPA, DLFAACAP

Contact Us/Join Us

Program Administrator

Greg Miller, PharmD
Colorado Department of Health Care Policy and Financing
303 E. 17th Avenue
Denver, CO 80203

Openings for New Members

The Department has three open positions for the P&T Committee members.

Open positions for applicants are being accepted for the following positions for the terms beginning January 2023:

  • Specialty Physicians, Other (3 positions)
    • One physician who specializes in the practice of psychiatry
    • One physician of any specialty (2 positions)

Duties, membership and other term details can be found in the P&T Committee Policies and Procedures.

If interested in serving or know someone who would be qualified, please submit/have them submit a CV along with a completed Conflict of Interest form to:

Colorado Department of Health Care Policy and Financing
Attn: Greg Miller, PharmD
Fax to 303-866-3590 or email greg.l.miller@state.co.us

A CV is not required for the member representative position. A resume (or similar document) is acceptable.

Presenting Testimony

Interested parties who want to present at the meeting shall give at least 3 business days notice (by 5 p.m. MST), prior to the meeting, to Jessica Czechowski, Pharmacist Account Executive, by email at jlczechowski@magellanhealth.com and carbon copy Greg Miller, PDL Pharmacist, by email at greg.l.miller@state.co.us. Please see the specific deadline for testimony on the meeting agenda.

Please see the P&T Committee Policies and Procedures for both written and verbal comments.

Reasonable accommodations for the meetings will be provided upon request for persons with disabilities. Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.